ADMA Biologics Inc Change in Accounts Receivable 2013-2025 | ADMA
ADMA Biologics Inc change in accounts receivable for the twelve months ending March 31, 2025 was $-0.097B, a 36.88% increase year-over-year.
- ADMA Biologics Inc annual change in accounts receivable for 2024 was $-0.023B, a 89.48% increase from 2023.
- ADMA Biologics Inc annual change in accounts receivable for 2023 was $-0.012B, a 191.16% decline from 2022.
- ADMA Biologics Inc annual change in accounts receivable for 2022 was $0.013B, a 185.22% decline from 2021.